Clinical trial Recruiting at 1 site Interventional Ages 30 to 50

Neuromuscular Re-education for Cervical Radiculopathy

Official title: Effects of Neuromuscular Re-education on Pain, Range of Motion and Disability in Patients With Cervical Radiculopathy

Run by Riphah International University · NCT07506200 · Data updated 2026-11-12

Aims to see if neuromuscular re-education can help reduce neck-related pain, improve movement, and lessen disability for adults with unilateral arm symptoms from cervical radiculopathy.

Quick facts

Study typeInterventional
Ages30 Years to 50 Years
SexAll
Enrollment52 (estimated)
SponsorRiphah International University
Academic / other
Locations1 site (Sialkot, Punjab Province)
StatusRecruiting
StartedMarch 1, 2026
Main results expectedJune 16, 2026
Study endsJuly 15, 2026
Registry record updatedJune 10, 2026
Trial IDNCT07506200 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 30-50 with unilateral upper extremity pain, paresthesia, or numbness for at least 3 months and specific clinical signs (Spurling’s test, distraction test, upper limb tension test positive, limited ipsilateral cervical rotation).

Probably not a fit

Individuals without the specified signs or with recent neck surgery or significant comorbidities may derive little to no benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares neuromuscular re-education to conventional physical therapy in adults aged 30-50 with unilateral neck pain and sensory symptoms lasting at least three months. It targets improvements in pain, range of motion, and functional disability using structured proprioceptive and task-specific exercises. Traditional therapies such as heat/cold application and general strengthening are used as a comparator. The investigation builds on prior work in motor control and postural re-education, seeking to clarify the added value of tailored neuromuscular re-education for cervical radiculopathy. The trial is conducted at National Hospital Sialkot with Riphah International University as lead sponsor.

Why it matters

Potential benefit: If successful, participants may experience reduced neck and arm pain, better neck movement, and less daily disability.

How similar studies have gone: Previous research shows some benefit from neuromuscular approaches, but evidence for cervical radiculopathy specifically is mixed and this study aims to add targeted data.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Participants of Age between 30 and 50 years old.
* Participants of both gender included.
* Participants having Unilateral upper extremity pain, paresthesia, or numbness
* Participants with Four positive findings required:
* Positive Spurling's test
* Positive distraction test
* Positive upper limb tension test
* Ipsilateral cervical rotation less than 60 degrees
* Participants must have experienced pain for at least 3 months.
* Participants must have a pain score of 4 to 6 on the 0-10 scale

Exclusion Criteria:

* Participants having prior cervical spine surgery.
* Participants with Cervical vertebral fracture
* Participants with severe osteoporosis, rheumatic disease, shoulder disease, or infection will be excluded.
* Participants with vertebro-basilar artery insufficiency and diabetic neuropathy

Where it's running

  • National hospital sialkot
    Sialkot, Punjab Province, Pakistan
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.